Notice regarding the conclusion of the Chinese distributor agreement
As of May 2021, we have entered into a contract with Shenzhen Lifetree Company Limited. (深圳紅杉数据健康有限公司 Headquarters: Shenzhen, China, hereinafter “Shenzhen Lifetree”) as a sales agent. We would like to inform you as follows.
- 1. Reason for concluding the contract
Through Shenzhen Lifetree, various health supplements that emphasize the actual effect, and other made in japan (made in Japan), whose role in preventing lifestyle-related diseases and diabetes is attracting attention in Japan for Chinese people. We will export health supplements that have excellent effects.
In addition, we will research and develop cutting-edge equipment and OTC using Big Data technology and propose them to Chinese people.
- Contract overview
Under this agreement, the Company grants Shenzhen Lifetree the exclusive right to sell the products of the Japan Healthcare Institute Inc. in China. The agreement will come into effect as of today, and the supply of products from the Japan Healthcare Institute Inc. to the company will begin.